CCAB offers a robust portfolio of validated antibodies that can serve as excellent research tools, primarily in the field of immunobiology, including Flow Cytometry and ELISA. Our expertise lies in the rigorous selection of binders against human proteins that are essential in a versatile number of cell signalling pathways involved in cancer and autoimmune diseases. The growing portfolio of validated antibody reagents, tools and technologies will soon be available for distribution and licensing.
Would you like us to contact you when we launch? Send us an email.